Literature DB >> 12760991

The effects of local and intravenous anesthetics on recombinant rat VR1 vanilloid receptors.

Kazuyoshi Hirota1, Darren Smart, David G Lambert.   

Abstract

UNLABELLED: Capsaicin, acting at the vanilloid 1 receptor (VR1), may potentiate local anesthetic activity, and as a ligand-gated ion channel of the transient receptor potential family, may also be a target for IV general anesthetics. We have examined whether local (lidocaine, prilocaine, and procaine 0.1-10 mM; 10 mM represents 0.25%-0.27% wt/vol) or IV anesthetics (propofol 10 micro M, thiopental 100 micro M, and ketamine 100 micro M) interact with recombinant rat VR1 expressed in human embryonic kidney (HEK293) cells (VR1-HEK293). We have assessed receptor interaction functionally by monitoring intracellular Ca(2+) ([Ca(2+)](i)) in Fura2-loaded cells at 37 degrees C. The addition of capsaicin (60 nM) produced a time-dependent biphasic increase in [Ca(2+)](i) amounting to 50-100 nM above than basal, which was inhibited by capsazepine 10 micro M and was absent in wild type HEK293 cells. Lidocaine and prilocaine alone (e.g., at 10 mM) significantly increased [Ca(2+)](i) by 67 +/- 6 nM and 33 +/- 7 nM, respectively, and concentration-dependently inhibited the capsaicin response. The effects of procaine were obscured by anesthetic-induced quenching of Fura2. In wild type HEK293 cells, lidocaine (10 mM) alone produced a small increase in [Ca(2+)](i). All IV anesthetics failed to modify capsaicin-increased [Ca(2+)](i). In conclusion, the present data suggest that local but not IV general anesthetics interact with recombinant rat VR1 receptors with the former anesthetics having antagonistic activity. IMPLICATIONS: Vanilloid receptors (VR1) are activated by capsaicin, the pain-producing component of hot chili peppers. We suggest that local (but not IV general) anesthetics may have inhibitory actions on this receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12760991     DOI: 10.1213/01.ane.0000061580.89627.91

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  Differential effects of bupivacaine and tetracaine on capsaicin-induced currents in dorsal root ganglion neurons.

Authors:  Hirochika Komai; Thomas S McDowell
Journal:  Neurosci Lett       Date:  2005-01-24       Impact factor: 3.046

2.  Propofol modulates agonist-induced transient receptor potential vanilloid subtype-1 receptor desensitization via a protein kinase Cepsilon-dependent pathway in mouse dorsal root ganglion sensory neurons.

Authors:  Peter J Wickley; Ryo Yuge; Mary S Russell; Hongyu Zhang; Michael A Sulak; Derek S Damron
Journal:  Anesthesiology       Date:  2010-10       Impact factor: 7.892

3.  Magnesium sulfate with lidocaine for preventing propofol injection pain: a randomized, double-blind, placebo-controlled trial.

Authors:  Richard E Galgon; Peter Strube; Jake Heier; Jeremy Groth; Sijian Wang; Kristopher M Schroeder
Journal:  J Anesth       Date:  2014-08-06       Impact factor: 2.078

4.  New formulations of local anaesthetics-part I.

Authors:  Edward A Shipton
Journal:  Anesthesiol Res Pract       Date:  2011-12-05

5.  The salty and burning taste of capsaicin.

Authors:  Sidney A Simon; Ivan E de Araujo
Journal:  J Gen Physiol       Date:  2005-06       Impact factor: 4.086

6.  Paradoxic effects of propofol on visceral pain induced by various TRPV1 agonists.

Authors:  Wenjin Ji; Can Cui; Zhiwei Zhang; Jiexian Liang
Journal:  Exp Ther Med       Date:  2013-02-05       Impact factor: 2.447

7.  Deletion of vanilloid receptor (TRPV1) in mice alters behavioral effects of ethanol.

Authors:  Y A Blednov; R A Harris
Journal:  Neuropharmacology       Date:  2009-03       Impact factor: 5.273

8.  Deep sequencing and miRNA profiles in alcohol-induced neuroinflammation and the TLR4 response in mice cerebral cortex.

Authors:  J R Ureña-Peralta; S Alfonso-Loeches; C M Cuesta-Diaz; F García-García; C Guerri
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.